Free shipping on all orders over $ 500

Apalutamide (ARN-509)

Cat. No. M2270

All AbMole products are for research use only, cannot be used for human consumption.

Apalutamide (ARN-509) Structure
Synonym:

Apalutamide

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
10mM*1mL in DMSO USD 72  USD72 In stock
2mg USD 48  USD48 In stock
5mg USD 75  USD75 In stock
10mg USD 120  USD120 In stock
25mg USD 265  USD265 In stock
50mg USD 376  USD376 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Apalutamide (ARN-509) is a selective and competitive androgen receptor inhibitor with IC50 of 16 nM. ARN-509 inhibits AR nuclear translocation and AR binding to androgen response elements and, unlike bicalutamide, does not exhibit agonist properties in the context of AR overexpression. ARN-509 displayed dose-proportional pharmacokinetics, and demonstrated pharmacodynamic and antitumor activity across all dose levels tested. ARN-509 is currently in a Phase I clinical trial.

Product Citations
Chemical Information
Molecular Weight 477.43
Formula C21H15F4N5O2S
CAS Number 956104-40-8
Solubility (25°C) DMSO 40 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Rathkopf DE, et al. J Clin Oncol. Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancer.

Related Androgen Receptor Products
LGD-3303

LGD-3303 is a nonsteroidal, nonaromatizable selective androgen receptor ligand that binds to the androgen receptor with high affinity in a radiolabeled to competitive binding assay (Ki=0.9 nM).

Ar-V7-IN-1

Ar-V7-IN-1 is a potent inhibitor of Ar-V7. AR-V7 is a hormone-independent splice variant of the androgen receptor. Ar-V7-IN-1 has the potential for the research of various indications such as prostate cancer.

SC912

SC912 is a potent and selective AR-V7 inhibitor with IC50 of 0.36 μM. SC912 binds directly to AR-FL and AR-V7 proteins, inhibites nuclear localization and chromatin binding capabilities. SC912 exerts anticancer activity through inhibition of proliferation, induction of cell cycle arrest and apoptosis.

A4B17

A4B17 is an androgen receptor N-terminal inhibitor, which can be used for the research of androgen-responsive prostate cancer.

AZ'3137 

AZ‘3137 is an orally active PROTAC-type androgen receptor (AR) degrader, with a DC50 value of 22 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: Apalutamide (ARN-509), Apalutamide supplier, Androgen Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.